Jennifer Tan

SABR in oligometastatic breast cancer: Current status and future directions.

Rachel Stewart, Michelle White, Jennifer Tan, Shankar Siva, Lama Karroum, Steven David

Journal article  |  2021  |  Breast

Oligometastatic breast cancer (OMBC) is a heterogeneous disease with intrinsic biological diversity. It is increasingly accepted i..

Enhanced toxicity with CDK 4/6 inhibitors and palliative radiotherapy: Non-consecutive case series and review of the literature

Steven David, Gwo Ho, Daphne Day, Marion Harris, Jennifer Tan, Shom Goel, Gerard G Hanna, Ranjana Srivastava, Gill Kruss, Lachlan McDowell, Michelle White

Journal article  |  2021  |  TRANSLATIONAL ONCOLOGY

Current first-line systemic treatment in most patients with metastatic hormone receptor-positive, HER-2 negative breast cancer is ..

Single-fraction stereotactic ablative body radiotherapy for sternal metastases in oligometastatic breast cancer: Technique and single institution experience

Michelle P Li, Dianne Kelly, Jennifer Tan, Shankar Siva, Tomas Kron, Steven David

Journal article  |  2020  |  JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY

INTRODUCTION: Due to size and close proximity to skin, the sternum is a complicated target for stereotactic ablative body radiothe..

Stereotactic ablative body radiotherapy (SABR) for bone only oligometastatic breast cancer: A prospective clinical trial

Steven David, Jennifer Tan, Peter Savas, Mathias Bressel, Dianne Kelly, Farshad Foroudi, Sherene Loi, Shankar Siva

Journal article  |  2020  |  BREAST

BACKGROUND: Stereotactic ablative body radiotherapy (SABR) is an emerging noninvasive approach for the treatment of oligometastase..